Vibrant Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vibrant Therapeutics - overview
Established
2019
Location
Cambridge, MA, US
Primary Industry
Pharmaceuticals
About
Based in the US, and established in 2019, Xinhua Biopharmaceuticals (Guangzhou) Co. , Ltd. trading as Vibrant Therapeutics, is a biopharmaceutical company that focuses on R&D of macromolecular drugs taking the technology of artificial intelligence (AI). The company's founder is Larry Wang.
In January 2026, Vibrant Therapeutics raised USD 61 million in venture funding from Apricot Capital, Pfizer Venture Investments, Bayland Capital, HSG, NLVC. and First Principal Venture Limited. The company developes an AI-driven macromolecular drug research platform that supports target identification, molecular design and efficacy evaluation. The company also launched VibrantFold, an antibody structure prediction tool.
Its drug candidates focus primarily on immuno-oncology applications, particularly for the treatment of solid tumors. The company generates revenue through collaborative R&D partnerships, licensing of its AI-enabled drug discovery tools and the development of proprietary macromolecular drug candidates for oncology and immune-related diseases. The company plans to utilize the January 2026 funding for advancement of pipeline, development of proprietary drug design platform, and expansion of team for global development activities.
Current Investors
MPC, HSG, Redhill Capital
Primary Industry
Pharmaceuticals
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development, Medical Software
Website
www.vibrantx.com/
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.